The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
Open accessAbstract
Background Persistent inflammation has been proposed to contribute to various stages in the pathogenesis of cardiovascular disease. Interleukin-6 receptor (IL6R) signalling propagates downstream inflammation cascades. To assess whether this pathway is causally relevant to coronary heart disease, we studied a functional genetic variant known to affect IL6R signalling.Methods In a collaborative meta-analysis, we studied Asp358Ala (rs2228145) in IL6R in relation to a panel of conventional risk factors and inflammation biomarkers in 125,222 participants. We also compared the frequency of Asp358Ala in 51,441 patients with coronary heart disease and in 136,226 controls. To gain insight into possible mechanisms, we assessed Asp358Ala in relation to localised gene expression and to postlipopolysaccharide stimulation of interleukin 6.Findings The minor allele frequency of Asp358Ala was 39%. Asp358Ala was not associated with lipid concentrations, blood pressure, adiposity, dysglycaemia, or smoking (p value for association per minor allele ≥0·04 for each). By contrast, for every copy of 358Ala inherited, mean concentration of IL6R increased by 34·3% (95% CI 30·4-38·2) and of interleukin 6 by 14·6% (10·7-18·4), and mean concentration of C-reactive protein was reduced by 7·5% (5·9-9·1) and of fibrinogen by 1·0% (0·7-1·3). For every copy of 358Ala inherited, risk of coronary heart disease was reduced by 3·4% (1·8-5·0). Asp358Ala was not related to IL6R mRNA levels or interleukin-6 production in monocytes.Interpretation Large-scale human genetic and biomarker data are consistent with a causal association between IL6R-related pathways and coronary heart disease.Funding British Heart Foundation; UK Medical Research Council; UK National Institute of Health Research, Cambridge Biomedical Research Centre; BUPA Foundation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“genetic evidence suggests that IL-6 may be causal for atherosclerotic cardiovascular disease, 24,25”
From Comprehensive Long-Term Changes in Cardiovascular Risk Biomarkers With Tirzepatide (2026) · cites this paper as [24]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Progress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010
Scott, D. L., Wolfe, F., & Huizinga, T. W. J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60826-4 · Cited by 3,263
Ridker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429
The immune system in atherosclerosis
Hansson, G. K., & Hermansson, A. (2011) · Nature Immunology · doi:10.1038/ni.2001 · Cited by 2,389
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
Cardiogenics, Schunkert, H., the CARDIoGRAM Consortium, König, I. R., Kathiresan, S., Reilly, M. P., Assimes, T. L., Holm, H., Preuss, M., Stewart, A. F. R., et al. (2011) · Nature Genetics · doi:10.1038/ng.784 · Cited by 1,866
Plasma Fibrinogen Level and the Risk of Major Cardiovascular Diseases and Nonvascular Mortality
Danesh, J., Lewington, S., Thompson, S. G., Lowe, G. D. O., Collins, R., Kostis, J. B., Wilson, A. C., Folsom, A. R., Wu, K., Benderly, M., et al. (2005) · JAMA · doi:10.1001/jama.294.14.1799 · Cited by 1,162
Population genomics of human gene expression
Stranger, B. E., Nica, A. C., Forrest, M. S., Dimas, A. S., Bird, C., Beazley, C., Ingle, C., Dunning, M., Flicek, P., Koller, D., et al. (2007) · Nature Genetics · doi:10.1038/ng2142 · Cited by 1,153
Genomics, type 2 diabetes, and obesity
McCarthy, M. I. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0906948 · Cited by 938
Research works printed but not linked: 2
- Lamas, 2011, Mechanisms underlying the generation of soluble IL-6 soluble receptor (sIL-6R) in rheumatoid arthritis: mRNA alternative splicing and proteolytic cleavage as independent contributors, Arthritis Rheum, 63, 383
- Genovese, 2009, Analysis of low-density lipoprotein and adverse events in rheumatoid arthritis patients treated with tocilizumab plus statins: data from five phase III clinical trials, Rheumatology (Oxford), 48, I81
Cited by
Sorted by citations
Items 801–823 of 823
Introduction to comorbidities, extra-articular and extra-musculoskeletal manifestations
Dey, M., & Nikiphorou, E. (2026) · Technical report · doi:10.1016/b978-0-443-23722-5.00002-9
Alduhayhi, S. S., Morris, A. P., Zhao, S. S., & Bowes, J. (2026) · medRxiv · doi:10.64898/2026.06.09.26355246
Kim, J.-K., Lee, Y.-J., Kim, J., Kim, H. C., Park, C. H., Koh, H. B., Kim, H. W., & Han, S. H. (2026) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000001156
Inflammatory activation and MAPK signaling mediate fumonisin B1-induced myocardial dysfunction
Chen, L., Zhou, G., Fang, C., Zhu, J., Nie, D., Jin, Y., Han, Z., & Wang, Y. (2026) · Toxicology in Vitro · doi:10.1016/j.tiv.2026.106287
Biomarkers of Cardiovascular Stress: A Historical Review
Khosla, H., Kopel, J. J., Abohelwa, M., Awasthi, M., Mohlere, V., Singh, S. P., Shurmur, S. W., Ansari, M. A., Awasthi, Y., & Awasthi, S. (2026) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd13080358
Assessment of Some Immunological Parameters Among Ischemic Heart Disease in Iraqi Patients
Almadany, Z. M., & Shwaikh, A. K. (2026) · Medical Journal of Babylon · doi:10.4103/mjbl.mjbl_1738_23
Anti-inflammatory activity of an IL-6 missense variant against crystal-induced inflammatory response
Li, Y., Leng, J., Wen, N., Han, H., Wang, H., Song, Z., Liu, Q., Lu, X., & Gao, B. (2026) · Cytokine · doi:10.1016/j.cyto.2026.157202
Frikke‐Schmidt, R. (2026) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2026.101630
Vigerust, D. J., & Bale, B. F. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27177666
“Mendelian randomization studies using variants in or near the IL-6R locus have shown that genetically downregulated IL-6 receptor signaling is associated with lower lifetime risk of coronary heart disease and other vascular outcomes [55,56].”
The role of interleukin 6 in the development of cardiovascular pathology
Nasonov, E. L., Fomicheva, O. A., Baranov, A. A., Попкова, Т. В., & MIu, S. (2026) · Rheumatology Science and Practice · doi:10.47360/1995-4484-2026-335-357 · Cited by 1
Residual Inflammatory Risk of Heart Failure and Atherosclerotic CVD in Diabetes
Patel, K. V., Chiu, L., Garcia, K. R., Belalcazar, L. M., Segar, M. W., Butler, J., Espeland, M., Ballantyne, C. M., & Pandey, A. (2026) · JACC Heart Failure · doi:10.1016/j.jchf.2026.103296
Inzunza-Esparza, K., & García‐Escobar, A. (2026) · Life · doi:10.3390/life16091512
Kim, J. A., Kim, J. J., Ternes, C. M. P., Chelu, M. G., & Curtis, A. B. (2026) · JACC Advances · doi:10.1016/j.jacadv.2026.103285
Brüggemann, E., & Garbers, C. (2026) · Biochimie · doi:10.1016/j.biochi.2026.09.015
Hallab, A., The Health and Aging Brain Study (HABS-HD) Study Team*, O’Bryant, S. E., Yaffe, K. S., Toga, A. W., Rissman, R. A., Johnson, L. A., Braskie, M. N., King, K., Hall, J. R., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-69096-z · Cited by 4
“Large Mendelian randomization studies have demonstrated a causal effect of IL-6 and IL-6 receptors on CVD risk, as a genetic polymorphism responsible for lower IL-6 levels is associated with lower risks of CVD 80,81 and depression 19 .”
Yu, M., Sun, M.-Y., Yang, F., Yuan, Y.-F., Zhang, Y.-M., Ruan, C.-C., 季永, Libby, P., & Cheng, X. (2026) · 中国科学通报：英文版 · doi:10.1016/j.scib.2026.09.081
Vascular aging biomarkers: the role of ADMA, SDMA, and inflammation
Melnitskaia, A. A., Machekhina, L., Pykhtina, V. S., Churov, A., Maltseva, O., Wu, Z., Tkacheva, O., & Strazhesko, I. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1922813
Bezhanishvili, T. G., Semernin, Е. N., Davydova, V. G., Andreeva, S. E., Streltsova, A. A., Полякова, А. А., Kostareva, A. A., & Gudkova, A. Y. (2026) · The Scientific Notes of the Pavlov University · doi:10.24884/1607-4181-2026-33-2-40-48
Prabhakar, P. (2026) · Research Square · doi:10.21203/rs.3.rs-11115416/v1
Immune-Mediated Endothelial Injury in Cardiometabolic–Cardiovascular Disease
Wang, Q., Liu, L., Li, W., & Li, Y. (2026) · Biomedicines · doi:10.3390/biomedicines14112415
Fabunmi, O. A., Fabunmi, F. C., Olaiya, A. O., Dada, O. S., Dludla, P. V., & Nkambule, B. B. (2026) · Current Research in Physiology · doi:10.1016/j.crphys.2026.100194
Lifecycle tissue engineering: An AI-enabled multimodal sensing and digital twin roadmap
Liu, X., Zhou, Y., Wang, C., Tu, L., Zhao, X., Gu, J., Sun, Q., Xing, M. M. Q., & Yang, Y. (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2026.06.044
Sha, A., Wu, Y., Peng, H., Jin, B., He, B., Zhao, Z.-K., He, F., Cao, Y., & Lu, G. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-026-01949-9
Metadata
- Authors
- ‡
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- ‡
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2012-03
- Volume
- 379
- Issue
- 9822
- Pages
- 1205-1213
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC3316940
- OpenAlex
- W2139957955
- Cited by
- 823
- References
- 47
- Citations by year
- 2026: 48 · 2025: 46 · 2024: 63 · 2023: 46 · 2022: 50 · 2021: 69 · 2020: 73 · 2019: 57 · 2018: 61 · 2017: 60 · 2016: 58 · 2015: 48 · 2014: 72 · 2013: 48 · 2012: 23
- FWCI
- 7.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- The Lancet (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- UnissResearch (Università degli Studi di Sassari) (submittedVersion)
- Leicester Research Archive (University of Leicester) (submittedVersion, other-oa)
- Lund University Publications (Lund University) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Site cant be reached (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Bristol Research (University of Bristol) (submittedVersion)
- STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
- Funders
- British Heart Foundation (RG/08/014)
- Bupa Foundation
- Medical Research Council
- NIHR Cambridge Biomedical Research Centre
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- IL-6 receptor, coronary artery disease, rs2228145, genetic association, inflammation, C-reactive protein, fibrinogen, interleukin-6, chronic inflammation, cardiovascular risk factors, monocytes, gene expression
- MeSH terms
- Coronary Disease, Gene Frequency, Humans, Risk Factors, Genetic Variation, Signal Transduction, Causality, Inflammation Mediators, Receptors, Interleukin-6
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
